These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33971335)

  • 21. HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
    Matiello M; Schaefer-Klein J; Brum DG; Atkinson EJ; Kantarci OH; Weinshenker BG;
    Mult Scler; 2010 Aug; 16(8):981-4. PubMed ID: 20591987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of CH25H in multiple sclerosis and neuromyelitis optica.
    Forwell AL; Bernales CQ; Ross JP; Yee IM; Encarnacion M; Lee JD; Sadovnick AD; Traboulsee AL; Vilariño-Güell C
    J Neuroimmunol; 2016 Feb; 291():70-2. PubMed ID: 26857497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human leukocyte antigen association with neuromyelitis optica in a south Indian population.
    Pandit L; Malli C; D'Cunha A; Mustafa S
    Mult Scler; 2015 Aug; 21(9):1217-8. PubMed ID: 25698175
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypertrophic pachymeningitis accompanying neuromyelitis optica spectrum disorder: A case report.
    Kon T; Nishijima H; Haga R; Funamizu Y; Ueno T; Arai A; Suzuki C; Nunomura J; Baba M; Takahashi T; Tomiyama M
    J Neuroimmunol; 2015 Oct; 287():27-8. PubMed ID: 26439957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of neuromyelitis optica spectrum disorders - An update.
    Bruscolini A; Sacchetti M; La Cava M; Gharbiya M; Ralli M; Lambiase A; De Virgilio A; Greco A
    Autoimmun Rev; 2018 Mar; 17(3):195-200. PubMed ID: 29339316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of AQP4 Antibody Serostatus and its Prediction of Visual Outcome in Neuromyelitis Optica: A Systematic Review and Meta-Analysis.
    Lin N; Liu Q; Wang X; Ma J; Li Y
    Protein Pept Lett; 2017; 24(3):245-252. PubMed ID: 28071581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of rituximab in the treatment of neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
    Wang Y; Chang H; Zhang X; Yin L
    Mult Scler Relat Disord; 2021 May; 50():102843. PubMed ID: 33609924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromyelitis optica, atypical hemophagocytic lymphohistiocytosis and heterozygous perforin A91V mutation.
    Palterer B; Brugnolo F; Sieni E; Barilaro A; Parronchi P
    J Neuroimmunol; 2017 Oct; 311():10-13. PubMed ID: 28863861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of pediatric neuromyelitis optica.
    Lotze TE; Northrop JL; Hutton GJ; Ross B; Schiffman JS; Hunter JV
    Pediatrics; 2008 Nov; 122(5):e1039-47. PubMed ID: 18838462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic factors in multiple sclerosis and neuromyelitis optica].
    Sato S; Kira J
    Nihon Rinsho; 2014 Nov; 72(11):1918-23. PubMed ID: 25518371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report.
    Sahraian MA; Moghadasi AN; Owji M; Naghshineh H; Minagar A
    J Med Case Rep; 2015 Jun; 9():137. PubMed ID: 26059535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica.
    Moussawi K; Lin DJ; Matiello M; Chew S; Morganstern D; Vaitkevicius H
    J Clin Neurosci; 2016 Jan; 23():159-161. PubMed ID: 26412254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromyelitis optica: a new perspective.
    Pittock SJ
    Semin Neurol; 2008 Feb; 28(1):95-104. PubMed ID: 18256990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gluten sensitivity and neuromyelitis optica: two case reports.
    Jacob S; Zarei M; Kenton A; Allroggen H
    J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):1028-30. PubMed ID: 15965221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The latest diagnostic criteria and treatment options for neuromyelitis optica.
    Moore RR; Tanner M
    JAAPA; 2019 Jul; 32(7):1-6. PubMed ID: 31241616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exome and regulatory element sequencing of neuromyelitis optica patients.
    Siuko M; Valori M; Kivelä T; Setälä K; Morin A; Kwan T; Pastinen T; Tienari P
    J Neuroimmunol; 2015 Dec; 289():139-42. PubMed ID: 26616883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very short multifocal myelitis lesions as initial signs of neuromyelitis optica spectrum disorder.
    Seok JI; Park MS
    Acta Neurol Belg; 2020 Oct; 120(5):1203-1205. PubMed ID: 31290015
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuromyelitis optica spectrum disorder initiated with hemiageusia and pruritus: a case report.
    Wang R; Qi D; Zhang Y
    J Neurol Sci; 2015 Jan; 348(1-2):288-9. PubMed ID: 25486866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.